Submissions

Submission preparation checklist.

  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in OpenOffice, Microsoft Word document file format.
  • The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.

Author Guidelines

"Indian Journal of Medical Research and Pharmaceutical Sciences" accepts for conceivable reflection unpublished elevated scientific manuscripts. The insides should be neither fully, nor partially issued or under concern for periodical elsewhere.

The following word mainframe file formats are acceptable for the main manuscript document must be in Microsoft word (DOC, DOCX) IJMRPS_Template.docx

Manuscript must be submitted through online submission system or Emai:  [email protected]

Manuscripts will be subjected to peer review process to determine their suitability for publication provided they fulfill the requirements of the journal that usually does not exceed 3 months. After the review, the manuscript will be returned for revision along with the reviewer’s and /or editor’s comments. Authors should be submitting their manuscripts to “Indian Journal of Medical Research and Pharmaceutical Sciences” Editorial office via e-mail with attachment together a Covering Letter. Sample covering letter to download in “Indian Journal of Medical Research and Pharmaceutical Sciences” website. Manuscript submission file size does not exceed 20mb. Manuscripts sent to authors for revision should be returned by Online Submission System within 3 months in a submission of date. The e-mails and address of all authors & co-authors must be written in the sample covering letter. Please submit text, tables and figures in the same files. No hard-copies required to submit it’s your publication research article. Papers might be returned to authors without review if the Editors deliberated that, they settle out of scope of the Journal, fail to see the principles of scientific consequence and innovation, or if they are considered too basic.

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

Make a Submission

Email manuscript.

[email protected]

Information

  • For Readers
  • For Authors
  • For Librarians

Current Issue

Developed by.

ISSN: 2349-5340

Submissions

Submission preparation checklist.

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in OpenOffice, Microsoft Word, or RTF document file format.
  • Where available, URLs for the references have been provided.
  • The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.

Please fill in the copyright transfer file and add it along with the submission: https://ojs.ijcp.in/IJCP/libraryFiles/downloadPublic/1

Author Guidelines

Submitting Translations/Secondary Publications to Indian Journal of Clinical Practice (IJCP) - Guidelines

The Indian Journal of Clinical Practice (IJCP) permits translations or secondary publications of prior published works under certain circumstances.

The following guidelines have been developed drawing on the International Committee of Medical Journal Editors (ICMJE) recommendations and they must be adhered ro when submitting an article:

  • Permission: Authors must obtain permission for a secondary publication from the editors of both the journal in which the original work was published and IJCP.
  • Transparency: When submitting a translation or secondary publication, authors are required to clearly disclose in the submission letter that the manuscript is a translation of an earlier work. They should also provide a copy of the original work.
  • Reference to The Original Publication: A complete reference to the original work must be included in the abstract and also in the reference list of the translation or secondary publication.
  • Verification: All submissions of translations must conform to the policies of the IJCP on the translations and the ICMJE. The policies on translations can be found [here](website URL here).
  • Rationale: Authors are asked to justify why they think a secondary publication is necessary, as part of their cover letter. This might be because the translation makes the work accessible to a different audience and the work is of clinical relevance or has implications for public health.

Remember, the IJCP and its editors have the final authority to accept or reject a manuscript for publication.

For further information and context, authors are encouraged to review the ICMJE recommendations on overlapping publications here . If in doubt, authors should contact the editorial board to discuss potential submissions.

Ethics and Publishing Policy for Indian Journal of Clinical Practice (IJCP)

The Indian Journal of Clinical Practice (IJCP) is committed to upholding ethical standards in academic publishing and ensuring the content published in our journal meets the highest levels of integrity. To achieve this, IJCP adheres to the following guidelines and principles:

  • COPE Principles of Transparency and Best Practice : IJCP follows the guidelines provided by the Committee on Publication Ethics (COPE), ensuring transparency, publication ethics, and best practices for all parties involved in the publication process. More details on COPE's guidelines can be found here .
  • ICMJE Recommendations : The journal abides by the International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals. For more information on these recommendations, please visit the ICMJE website .
  • Conflicts of Interest : All authors, reviewers, and editors must declare any potential conflicts of interest that may influence their work. Conflicts of interest should be disclosed within the manuscript and during the review process.
  • Authorship Criteria : IJCP follows the ICMJE authorship guidelines, specifying that authors must meet all four criteria:
  • Substantial contributions to the conception or design of the work, acquisition, analysis, or interpretation of data
  • Drafting the work or revising it critically for intellectual content
  • Final approval of the version to be published.
  • Agreement to be accountable for all aspects of the work.
  • Informed Consent and Human Research : Manuscripts involving human subjects must have appropriate ethics committee approval and informed consent. Research participants’ identities should remain confidential.
  • Animal Research : Animal studies must adhere to relevant guidelines, such as the ARRIVE guidelines, and any necessary research ethics committee approvals must be stated in the manuscript.
  • Data Availability : Authors should make their research data available for further study upon request, if it maintains the confidentiality and privacy of research participants, where applicable.
  • Response to Misconduct and Plagiarism : IJCP takes all allegations of research misconduct and plagiarism seriously. In cases of suspected misconduct, IJCP follows the procedures outlined by COPE for addressing and resolving such allegations.

By adhering to these ethical guidelines and principles, the Indian Journal of Clinical Practice is committed to maintaining the highest standards of academic publishing and research integrity. All submitted manuscripts must abide by these policies to be considered for publication in IJCP.

Plagiarism and Decision Process for Indian Journal of Clinical Practice (IJCP) Based on COPE and ICMJE

IJCP is highly committed to maintaining the highest standards of integrity, originality, and ethical conduct in the field of academic publishing. In this regard, it strictly adheres to the guidelines provided by the 'Committee on Publication Ethics (COPE)' and 'International Committee of Medical Journal Editors (ICMJE)' for handling plagiarism and conducting the decision process effectively.

Plagiarism is treated as a serious ethical violation and act of misconduct in the IJCP:

  • Definition: IJCP follows the COPE and ICMJE definitions of plagiarism which regard it as the presentation of someone else's published or unpublished work or ideas without appropriate attribution or permission.
  • Detection: All submissions to IJCP undergo rigorous plagiarism checks using advanced software tools like iThenticate and Turnitin.
  • Action: In any case of detected plagiarism, COPE's guidelines are strictly followed. Initial steps may include contacting the author for clarification and if plagiarism is confirmed, this can lead to the outright rejection of the manuscript. Serious cases of plagiarism may also result in the author being barred from future submissions to the journal.

Decision Process

The decision process at IJCP has been designed adhering to ethical guidelines recommended by both COPE and ICMJE:

  • Peer Review: All submitted manuscripts are subjected to a rigorous peer review process. The reviewers chosen are experts in the relevant field who provide unbiased, accurate, and constructive assessment of the manuscript.
  • Editorial Decision: After thorough review, the editorial team makes a decision about the manuscript. The decision could be acceptance, minor/major revision, or rejection.
  • Fair Play: IJCP follows COPE and ICMJE's principles of fairness and integrity. Manuscripts are evaluated on academic merit, relevance, new contributions, and the originality of research irrespective of race, gender, religious belief, ethnicity, or political philosophy of the authors.
  • Respect for Appeals: Authors may appeal editorial decisions by submitting written appeal letters detailing their responses to the reviewers and editors' comments. IJCP treats all such appeals with respect and handles them in accordance with COPE's guidelines and practices.

By adhering to these COPE and ICMJE-based guidelines on plagiarism and decision making, IJCP ensures that it upholds the highest level of ethical standards in academic publishing.

Fees and Charges

The Indian Journal of Clinical Practice (IJCP) is committed to delivering high-quality publications while maintaining accessible pricing for authors. We would like to inform prospective authors that the publication fee for an article in our journal is INR 5,000.

This fee covers essential costs associated with the administrative, technical, and production aspects of the publishing process. By charging this fee, we ensure the timely and professional publication of your research, ultimately allowing your work to spark conversations and contribute to scientific advancements.

We appreciate your interest in publishing with IJCP and look forward to helping share your research with our global community.

Research Methodologies

IJCP recognizes and welcomes diverse research methodologies, including both quantitative and qualitative approaches. Any research contributing towards the field of clinical practice is encouraged.

Manuscript Preparation Guidelines

Manuscripts should be prepared in accordance with the ‘Uniform requirements for manuscripts submitted to biomedical journals’ compiled by the  International Committee of Medical Journal. Indian Journal of Clinical Practice strongly disapproves of the submission of the same articles simultaneously to different journals for consideration as well as duplicate publication and will decline to accept fresh manuscripts submitted by authors who have done so.  The boxed checklist (provided at the end) will help authors in preparing their manuscript according to our requirements. Improperly prepared manuscripts may be returned to the author without review. The checklist should accompany each manuscript. Authors may provide on the checklist, the names and addresses of experts from Asia and from other parts of the World who, in the authors’ opinion, are best qualified to review the paper. Covering letter – The covering letter should explain if there is any deviation from the standard IMRAD format (Introduction, Methods, Results and Discussion) and should outline the importance of the paper. – Principal/Senior author must sign the covering letter indicating full responsibility for the paper submitted, preferably with signatures of all the authors. – Articles must be accompanied by a declaration by all authors stating that the article has not been published in any other Journal/Book. Authors should mentioned complete designation and departments, etc. on the manuscript. Manuscript – Three complete sets of the manuscript should be submitted, typed double spaced throughout (including references, tables and legends to figures). – The manuscript should be arranged as follow: Covering letter, Checklist, Title page, Abstract, Keywords (for indexing, if required), Introduction, Methods, Results, Discussion, References, Tables, Legends to Figures and Figures. – All pages should be numbered consecutively beginning with the title page. Note: Please keep a copy of your manuscript as we are not responsible for its loss in the mail. Manuscripts will not be returned to authors. Title page Should contain the title, short title, names of all the authors (without degrees or diplomas), names and full location of the departments and institutions where the work was performed, name of the corresponding authors, acknowledgment of financial support and abbreviations used. – The title should be of no more than 80 characters and should represent the major theme of the manuscript. A subtitle can be added if necessary. – A short title of not more than 50 characters (including inter-word spaces) for use as a running head should be included. – The name, telephone and fax numbers, e-mail and postal addresses of the author to whom communications are to be sent should be typed in the lower right corner of the title page. – A list of abbreviations used in the paper should be included. In general, the use of abbreviations is discouraged unless they are essential for improving the readability of the text. Summary – The summary of not more than 200 words. It must convey the essential features of the paper. – It should not contain abbreviations, footnotes or references. Introduction – The introduction should state why the study was carried out and what were its specific aims/objectives. Methods – These should be described in sufficient detail to permit evaluation and duplication of the work by others. – Ethical guidelines followed by the investigations should be described. Statistics The following information should be given: – The statistical universe i.e., the population from which the sample for the study is selected. – Method of selecting the sample (cases, subjects, etc. from the statistical universe). – Method of allocating the subjects into different groups. – Statistical methods used for presentation and analysis of data i.e., in terms of mean and standard deviation values or percentages and statistical tests such as Student’s ‘t’ test, Chi-square test and analysis of variance or non-parametric tests and multivariate techniques. – Confidence intervals for the measurements should be provided wherever appropriate. Results – These should be concise and include only the tables and figures necessary to enhance the understanding of the text. Discussion – This should consist of a review of the literature and relate the major findings of the article to other publications on the subject. The particular relevance of the results to healthcare in India should be stressed, e.g., practicality and cost. References These should conform to the Vancouver style. References should be numbered in the order in which they appear in the texts and these numbers should be inserted above the lines on each occasion the author is cited (Sinha12 confirmed other reports13,14...). References cited only in tables or in legends to figures should be numbered in the text of the particular table or illustration. Include among the references papers accepted but not yet published; designate the journal and add ‘in press’ (in parentheses). Information from manuscripts submitted but not yet accepted should be citedin the text as ‘unpublished observations’ (in parentheses). At the end of the article the full list of references should include the names of all authors if there are fewer than seven or if there are more, the first six followed by et al., the full title of the journal article or book chapters; the title of journals abbreviated according to the style of the Index Medicus and the first and final page numbers of the article or chapter. The authors should check that the references are accurate. If they are not this may result in the rejection of an otherwise adequate contribution. Examples of common forms of references are: Articles Paintal AS. Impulses in vagal afferent fibres from specific pulmonary deflation receptors. The response of those receptors to phenylguanide, potato S-hydroxytryptamine and their role in respiratory and cardiovascular reflexes. Q. J. Expt. Physiol. 1955;40:89-111. Books Stansfield AG. Lymph Node Biopsy Interpretation Churchill Livingstone, New York 1985. Articles in Books Strong MS. Recurrent respiratory papillomatosis. In: Scott Brown’s Otolaryngology. Paediatric Otolaryngology Evans JNG (Ed.), Butterworths, London 1987;6:466-470. Tables – These should be typed double spaced on separate sheets with the table number (in Roman Arabic numerals) and title above the table and explanatory notes below the table. Legends – These should be typed double spaces on a separate sheet and figure numbers (in Arabic numerals) corresponding with the order in which the figures are presented in the text. – The legend must include enough information to permit interpretation of the figure without reference to the text. Figures – Two complete sets of glossy prints of high quality should be submitted. The labelling must be clear and neat. – All photomicrographs should indicate the magnification of the print. – Special features should be indicated by arrows or letters which contrast with the background. – The back of each illustration should bear the first author’s last name, figure number and an arrow indicating the top. This should be written lightly in pencil only. Please do not use a hard pencil, ball point or felt pen. – Color illustrations will be accepted if they make contribution to the understanding of the article. – Do not use clips/staples on photographs and artwork. – Illustrations must be drawn neatly by an artist and photographs must be sent on glossy paper.

No captions should be written directly on the photographs or illustrations. Legends to all photographs and illustrations should be typed on a separate sheet of paper. All illustrations and figures must be referred to in the text and abbreviated as “Fig.”.

Please complete the following checklist and attach it to the manuscript dit Copyright Notice

Copyright Notice

The copyright for all the editorial material contained in Indian Journal of Clinical Practice, in the form of layout, content including images and design, is held by IJCP Publications Ltd. No part of this publication may be published in any form whatsoever without the prior written permission of the publisher. Indian Journal of Clinical Practice does not guarantee, directly or indirectly, the quality or efficacy of any product or service described in the advertisements or other material which is commercial in nature in this issue.

U.S. flag

An official website of the United States government

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

  • Publications
  • Account settings
  • Advanced Search
  • Journal List
  • Indian J Anaesth
  • v.60(1); 2016 Jan

The revised guidelines of the Medical Council of India for academic promotions: Need for a rethink

Rakesh aggarwal.

Former Editor, Indian Journal of Gastroenterology, The National Medical Journal of India

Nithya Gogtay

1 Editor, Journal of Postgraduate Medicine, The National Medical Journal of India

Rajeev Kumar

2 Editor, Indian Journal of Urology, The National Medical Journal of India

Peush Sahni

3 Editor, The National Medical Journal of India

Zaffar Abbas, Editor, JK Practitioner,

Philip Abraham, Former Editor in Chief, Indian Journal of Gastroenterology,

Amita Aggarwal, Editor, Indian Journal of Rheumatology,

S Bala Bhaskar, Editor in Chief, Indian Journal of Anaesthesia,

Soumyadeep Bhaumik, Executive Editor, Journal of Family Medicine and Primary Care,

KK Deepak, Executive Editor, Indian Journal of Physiology and Pharmacology,

Chetna Desai, Chief Editor, Indian Journal of Pharmacology,

Madhu C Divakar, Editor in Chief, Hygeia: Journal for Drugs and Medicines,

Apul Goel, Associate Editor, Indian Journal of Urology,

V Gopi Krishna, Editor in Chief, Journal of Conservative Dentistry,

Anju Grewal, Chief Editor, Journal of Anaesthesiology Clinical Pharmacology,

OP Gupta, Editor in Chief, Journal of Mahatma Gandhi Institute of Medical Sciences,

Praveen Iyer, Assistant Editor, Journal of Postgraduate Medicine,

Vishakha Jain, Assistant Editor, Journal of Mahatma Gandhi Institute of Medical Sciences,

Amar Jesani, Editor, Indian Journal of Medical Ethics,

SM Kadri, Editor in Chief, Global Journal of Medicine and Public Health,

Arti Kapil, Editor, Indian Journal of Medical Microbiology,

Vishwa Mohan Katoch, Editor, Indian Journal of Leprosy,

GK Kulkarni, Editor, Indian Journal of Occupational and Environmental Medicine,

Adarsh Kumar, Web Editor, International Journal of Health Research and Medico Legal Practice,

Santosh Kumar, Associate Editor, Indian Journal of Urology,

GM Malik, Chief Editor, JK Practitioner,

Mohandas K Mallath, Member, Editorial Board, Ecancer Medical Science,

Vijay P Mathur, Former Member, Editorial Board, Journal of Indian Society of Pedodontics and Preventive Dentistry,

Sundeep Mishra, Honorary Editor, Indian Heart Journal,

Vatsala Misra, Editor in Chief, Indian Journal of Pathology and Microbiology,

Alladi Mohan, Editor, Journal of Clinical and Scientific Research,

Samiran Nundy, Editor, Current Medicine Research and Practice,

Sanjay A Pai, Member, Working Editorial Group, Indian Journal of Medical Ethics,

Bhushan Patwardhan, Editor in Chief, Journal of Ayurveda and Integrative Medicine,

Amitabh Prakash, Editor in Chief, Clinical Pharmacokinetics,

BS Ramakrishna, Editor in Chief, Indian Journal of Gastroenterology,

V Raveenthiran, Editor, Journal of Neonatal Surgery,

HPS Sachdev, Former Editor in Chief, Indian Pediatrics,

Yogesh K Sarin, Editor in Chief, Journal of Neonatal Surgery,

Chinmay Shah, Editor, National Journal of Integrated Research in Medicine,

Dheeraj Shah, Editor in Chief, Indian Pediatrics,

PVLN Srinivasa Rao, Executive Editor in Chief, Journal of Clinical and Scientific Research,

Nandini Suresh, Associate Editor, Journal of Conservative Dentistry,

George Thomas, Former Editor, Indian Journal of Medical Ethics,

Mukesh Yadav, Editor, Journal of Indian Academy of Forensic Medicine

Measuring academic achievements is never an easy task. This is particularly so when individuals are assessed for promotions in several fields with differing job descriptions. Assessment by peers is time-consuming and may be prone to bias; thus, objective criteria are required to minimise these concerns.

The Medical Council of India (MCI) has laid down guidelines for appointments and promotions of teachers in medical institutions in India. Among the criteria used for promotions, publication of research is an essential requirement. Though the need for this requirement has been debated, it is believed that the quality of teaching improves when medical teachers are involved in research. Many countries have made it mandatory for their medical faculty to do research; some other countries incentivise the conduct and publication of research. Reports have also lamented that the physician–scientist might become an endangered species.[ 1 , 2 ] Thus, linking publications with promotions might benefit both the individual and the society. The flip side is that the time spent on research might take teachers away from teaching or clinical duties, particularly in under-staffed speciality departments. Further, the quality of research is likely to be poor when the resources and training in research are lacking.[ 3 ] Poor quality may even discredit research as a professional activity. Insistence on a certain amount of published research to maintain teaching credentials may lead to the phenomenon of ‘publish or perish’.[ 4 ] Finally, it is important to consider that biomedical research may, at times, be relevant to non-biomedical journals and criteria for awarding credit to such publications should also be devised.

The MCI requires that the medical faculty engages in research. One measure to achieve this goal is the mandatory ‘thesis’ for postgraduate (Masters; MD/MS/DNB) and post-doctoral (DM/MCh/DNB) courses. Each student, regardless of speciality, is required to undertake a research study with a faculty member as the guide and often one-to-a-few faculty members from the same or related subjects as co-guides. Apart from providing training in doing research, the thesis is expected to inculcate an aptitude for research methodology and critical analysis. This experience is relevant to students who will become full-time researchers and is also beneficial to medical practitioners who may never conduct further research but should be able to discern the merits of newer management options for their patients.

The MCI's initial guidelines for promotion to the position of Associate Professor and Professor required publication of at least two research papers by the candidates.[ 5 ] In September 2015, the MCI issued a ‘clarification’ on what constitutes ‘research publications’ for the promotion of teaching faculty of medical colleges/institutions in India [ Box 1 ].[ 6 ] This ‘clarification’ raises the following issues.

Guidelines for counting research publications for promotion of teaching faculty of medical colleges/institutions in india as laid down in an order by Medical Council of India in September 2015

  • Indexing agencies: Scopus, PubMed, Medline, Embase / Excerpta Medica, Index Medicus and Index Copernicus
  • Types of articles to be considered: Original research articles and original research papers
  • Criteria for National/International journal: Published by a National/International – specialty journal/journal of a national/international society provided it is included in one of the indexes mentioned above
  • Authorship: First author, second author
  • e. E-journals: E-journals not included.

The above would also be applicable for ‘accepted for publication’ papers/articles.

The new guidelines stipulate that publications in e-journals will not be considered for promotion. This guideline is probably in response to the proliferation of predatory journals, almost exclusively among e-journals, over the past 5 years. It is worrying that the largest number of authors and publishers seem to be from India.[ 7 ] Predatory publishing is perhaps a manifestation of the ‘publish or perish’ phenomenon with authors willing to pay for publication.[ 7 ]

While the MCI's corrective measure is laudable, the definition of ‘e-journals’ is variable.[ 8 ] We assume that the MCI implies e-journals are those that do not have a print version. This guideline would exclude many high-quality journals that are published only in the electronic format, for example, the PLoS group of journals, the BioMed Central Journals, British Journal of Clinical Pharmacology and New Zealand Medical Journal. It might also exclude journals that publish papers in a longer e-version and a shorter print version (BMJ). Many believe that ‘paper journals’ of niche specialities (with limited circulation) may soon cease to appear. Publishing is rapidly shifting to the electronic format and an explosive growth in e-journals is envisaged. Thus, the embargo on all e-journals seems unfair. The main objective of this guideline appears to be to limit predatory publishing and to ensure quality. This can be achieved by insisting on other criteria such as indexing because reputed indexes are unlikely to include predatory journals.

Indexation or inclusion in select databases is an imperfect surrogate for quality. A more direct measure would probably be an assessment of each individual journal by peers. Until such an evaluation is available, we agree with the MCI's requirement that the journal of publication is listed in a recognised database. However, we suggest that the list of databases provided in the MCI's order needs a re-look. For example, Index Copernicus was last updated in 2014.[ 9 ] Some journals listed on this index and their publishers appear on Beall's list of potentially predatory journals.[ 10 ] In fact, Beall's blog says ‘Index Copernicus has no value’.[ 11 ] Although the MCI's order lists Medline and Index Medicus separately, these are actually one database. Similarly, PubMed is not a database but a search engine that searches various databases including Medline and PubMed Central. More important is the omission of Science Citation Index, an important database currently published by Thomson Reuters and of IndMed, a database of Indian Medical Journals, curated by the Indian Council of Medical Research. We suggest the following list of acceptable databases: Medline, PubMed Central, Science Citation Index, Embase/Excerpta Medica, Scopus and IndMed.

ARTICLE TYPES

The MCI guideline states that only ‘Original Research Articles’ and ‘Original Research Papers’ will be eligible for consideration. The objective here appears to be to include papers with original data and to exclude case reports and reviews or opinions. However, this guideline is not precise because different journals classify original research variously under these two and some other sections, such as brief communications and short reports. Further, this clause discredits meta-analyses and systematic reviews that involve scientific interpretation of original data. Instead of prescribing specific article-type labels, the MCI could suggest that the paper should report ‘original research data or its interpretation in a meta-analysis or systematic review’.[ 12 ] The guidelines’ implication that case reports, reviews and opinion pieces should not carry any value remains debatable since these are an important part of the scientific dialogue.

NATIONAL VERSUS INTERNATIONAL JOURNALS

The distinction between ‘National’ and ‘International’ journals is unclear. The inclusion of words such as ‘India’ or ‘Indian’ in the title does not necessarily make a journal one of lesser quality. Similarly, the presence of words such as ‘International’, ‘Global’ or ‘World’ in a journal's name does not confer it with a higher quality. National journals are in fact more likely to publish research that is relevant to the local population. Again, this discrimination by the MCI appears to be a surrogate marker for quality. Since indexing has already been included as a criterion, the terms ‘National’ and ‘International’ have little value. We also suggest that the criterion of Society journals be removed as indexation covers the quality requirements. The quality of a number of non-Society journals (e.g., the Lancet) is widely recognised.

PLACE IN AUTHORSHIP SEQUENCE

Finally, the MCI guideline of limiting credit to only the first two authors of a paper is too restrictive. This guideline seems to be an attempt to weed out the malpractice of gift authorship. Again, the MCI's aim is laudable, but the implementation can result in greater harm. The first name in a paper is generally associated with the person who did the maximum work, and the last name being that of the supervising senior.[ 13 ] The MCI guideline suggests that other names except the first two on the byline are those of ‘guests’.

The research scenario has moved towards collaborative and multidisciplinary projects conducted by large teams. To publish a paper in a high-quality journal, a researcher needs to look at a research problem from diverse aspects (e.g., clinical, laboratory, genetics and immunology). Hence, good papers often have multiple authors with an equal contribution, and all of them deserve equal credit.

The MCI guideline may not only deny credit to all those who have contributed, but it may also even encourage the practice of denying the first authorship, and credit, to junior researchers whose contribution is often the maximum. The experience of many medical editors shows that it is not uncommon to find the senior-most author as the first author (even in case reports) due to the premium placed on this position.[ 14 ] Therefore, we suggest that this guideline should be removed, and all the authors of a paper should receive credit for it.

We appreciate the MCI's intention to give research its due recognition in academic institutions as well as for streamlining the process of promotion of teachers. Our suggestions to amend the existing guidelines, summarised in Box 2 , can help remove ambiguities in the new MCI guidelines. These could also serve as the starting point of a wider consultation on the evaluation of research performance of medical teachers in India.

Our Suggestions

  • Medline, PubMed Central, Science Citation Index, Embase/Excerpta Medica, copus and IndMed
  • Articles reporting original research data or their interpretation in a meta-analysis or systematic review
  • All authors

Note: This editorial is being published simultaneously in the Indian Heart Journal, Indian Journal of Anaesthesia, Indian Journal of Gastroenterology, Indian Journal of Medical Ethics, Indian Journal of Medical Microbiology, Indian Journal of Occupational and Environmental Medicine, Indian Journal of Pathology and Microbiology, Indian Journal of Pharmacology, Indian Journal of Physiology and Pharmacology, Indian Journal of Urology, Indian Pediatrics, International Journal of Health Research and Medico Legal Practice, Journal of Anaesthesiology Clinical Pharmacology, Journal of Ayurveda and Integrative Medicine, Journal of Clinical and Scientific Research, Journal of Conservative Dentistry, Journal of Family Medicine and Primary Care, Journal of Indian Academy of Forensic Medicine, Journal of Mahatma Gandhi Institute of Medical Sciences, Journal of Postgraduate Medicine, National Journal of Integrated Research in Medicine and The National Medical Journal of India. It may also be published in forthcoming issues of other journals.

This editorial is not endorsed by all members of the Indian Association of Medical Journal Editors.

Page Header

A Journal of Healthcare Ethics & Humanities. Published since 1993 by Forum for Medical Ethics Society. Peer-reviewed. Indexed in Medline, PubMed, The Philosopher’s Index, Scopus.

SUBMISSION GUIDELINES

( Last updated February 08, 2022 )

The Indian Journal of Medical Ethics (IJME) is a multi-disciplinary journal of bioethics, healthcare ethics and humanities.

Before you submit your manuscript, please check whether its subject matter falls within the scope of the IJME. (For more information, please see “About IJME” )

The IJME is open access online, and the payment of article processing charge (APC) or publication fee by authors is voluntary (PWYW – Pay What You Want, including no payment). If your work or institution have financial support, we encourage you to make some payment to help make the journal sustainable. We also encourage readers accessing the full text or the pdf of a published article to pay whatever fee they can afford (PWYW, including no payment). However, access to the full-issue pdf and print issue is only on payment of subscription.

ETHICS OF PUBLICATION

Authors are expected to understand and comply with the principles of publication ethics. The IJME guidance for authors is based on the guidelines relating to ethics in publication developed by the Committee on Publication Ethics (COPE) and the International Committee of Medical Journal Editors (ICMJE). The COPE and ICMJE guidelines are followed on points not covered in the IJME guidelines for authors, and they are usually relied upon for resolution of any doubt or dispute.

ARTICLE TYPES AND SECTIONS OF THE JOURNAL

The IJME offers authors an opportunity to make submissions in a range of article types. Each article type has specific requirements (see table below). While preparing and submitting manuscripts, the author(s) may specify the article type. The final decision on categorising the article type of the manuscript rests with the editor. Each article published in the IJME will be identified by its type. In the issue of the journal, each article will be published in a section corresponding to the article type or in the sections based on a topic or theme (e.g. Covid-19, Law, or a specific theme in a theme issue, etc.).

ESSENTIAL INFORMATION ON SUBMISSION

(a) Originality: The submission is an original writing of author(s) and has not been published in, or submitted to other journal(s) for consideration.

(b) Pre-print Publication: Pre-print published manuscripts are eligible for submission to IJME. If your submission was published as pre-print, please provide a link to it and if it was revised before submission, provide information on the revision.

(c) Other similar publication(s): If your submission is based on findings of an empirical research and a part of findings were reported in other paper(s) already published, or awaiting publication, provide (i) copy of such publication(s) for scrutiny, and (ii) explanation that the findings used in the submission for the IJME have not been used in them. Please note that submissions reusing already reported findings make it redundant or salami, and may be declined – see ICMJE

(d) Data sharing: If the submission is based on findings of a primary empirical research conducted by author(s), please state whether and how the anonymised raw data will be shared with anybody interested in them.

2. Authorship and Author(s) information: The following information must be provided

(a) Eligibility for authorship: Only those who conform to the criteria for authorship as per Section IIA of the 2019 ICMJE recommendations ( http://www.icmje.org/recommendations/ ) may be listed as authors. Listing an ineligible person as author, denial of authorship to an eligible person and use of ghost-authors amount to misconduct that could result in rejection of a submission, or in retraction if already published.

(b) Contribution of each author: Please describe the specific contribution made by each author to the research and preparation of the submission.

(c) Signed undertaking by author(s): Each author must sign a statement in the cover letter that he/she/they have contributed as per the ICMJE requirements; read, approved and are responsible for the full content of the manuscript.

(d) Author(s) Details: For each author, the following information is essential

Name(s): Full name of each author and sequence of names (if multiple authors) as they should appear in the publication. The first name must be of the first author.

Corresponding author: In multi-authored submissions, please specify the author who will act as corresponding author. Also provide mailing address of corresponding author.

Affiliation of author(s): If an author is affiliated to an institution, mention not more than two affiliations for each author. Provide full name, address, and website of each institution to which affiliated.

Email ID of author(s): If affiliated to institution, please provide both institutional and personal IDs of each author.

Author(s)’ ORCID iD: We encourage authors to have ORCID registration and provide their ORCID iD .

(e) Disclosure of Conflict of Interest (CoI): Each author must disclose financial and other secondary interests having potential of conflict with the primary interest, i.e., the submission and its content. Please go through the details on the CoI here: ICMJE

Please note that the disclosure of CoI is mandatory. Each author must make an individual disclosure. Wilful non-disclosure of CoI is a misconduct and could result in retraction of a published article. We encourage authors to use the ICMJE disclosure form.

(f) Acknowledgment (of Non-Author contributors): Individuals who have contributed to the submission but are not eligible to be authors may be acknowledged by name (or in group) and for a specific contribution, after obtaining express permission(s). Non-author contributors do not endorse nor are responsible for the content of the submission.

3. Anonymous submission: As a rule, author(s) must identify themselves to the journal and readers. However, under some exceptional circumstances, IJME may permit author(s) to remain anonymous to readers. Such authors must identify themselves, in confidence, to the Editor, explain the need for anonymity and provide a copy of the submission for which anonymity is required. The decision on anonymity will be made on the basis of the author’s circumstances, the subject matter and points being made in the submission, and any other relevant material/issues.

4. Funding Support: Disclosure of funding support received for the research and/or preparation of the manuscript for submission is essential.

5. Research ethics and ethics approval: If the submission is based on information/data collected from human participants and/or animals, the methodology section must describe the ethics standards and principles observed in practice. Such submission must be accompanied by a copy of the ethics approval provided by a relevant Research Ethics Committee (REC). If the REC waived review and/or any ethics standard or approved verbal consent, please ensure that they are stated in the approval letter of the EC. Please note that in India the law mandates a prior approval of all health research by an REC. For more information, please see Section 4 of the ICMR Guidelines.

6. Cover-letter: Please use the cover-letter format as given on the website here . The cover-letter must contain all information on 1 to 6 components given above, and should be signed by all authors.

TEXT OF SUBMISSION

• Title of the submission

• Author(s) information with their affiliations, mailing addresses, telephone numbers and institutional and personal email ids ( in the sequence they should appear in the article )

• An abstract ( as per requirement mentioned in the Section for which the submission is made )

• Main Text of article: Please see word limits and other requirements as per the section for which it is submitted

• End-Notes and References: Please note (a) foot-notes are not allowed, (b) references should be in the style used by the IJME

• Tables/diagrams/charts/graphs: We do not publish any of them in colour, except in the online versions. Please submit them separately as rtf/doc files, and images as jpg files.

2. Use of inclusive language: Authors must try to use gender-neutral terminology whenever addressing general issues (regardless of a specific sex/gender). For example: use plural nouns like physicians/patients/reviewers instead of he/she. Exceptions: Articles/studies involving specific study populations, such as pregnant women should be described as such.

Avoid using stigmatising language/words related to mental health and disabilities. For example, use ‘died by suicide’ instead of ‘committed suicide’, ‘person with a disability’ instead of ‘disabled person’, or ‘person with brain injury’ instead of ‘brain damaged’.

Helpful resources:

United Nations’ Guidelines for gender-inclusive language in English: https://www.un.org/en/gender-inclusive-language/guidelines.shtml Words Matter: Guidelines for using inclusive language in the workplace (British Columbia Public Service): https://www2.gov.bc.ca/assets/gov/careers/all-employees/working-with-others/words-matter.pdf

3. Text with diacritical marks: Since IJME is also read by general readers, please avoid using text with diacritical marks except if used infrequently or if used in names.

FORMATTING OF THE MANUSCRIPT

1. Please format manuscripts as rtf/doc/docx in Times New Roman, 12 points. Submissions in PDF format are not acceptable.

o Use UK English.

o Avoid using ampersand and capitals within the sentences.

o Terminology needs to be consistent throughout the manuscript.

o The title and all headings should be in sentence case.

3. Alignment and spacing: The text should be left aligned with single-line spacing and double spacing between paragraphs.

4. Subheads: Do not number subheads or put them in capital letters. Please follow a single format. Multiple subheads should be differentiated as follows:

5. Endnotes: We do not carry footnotes in the text. Endnotes may be used only where absolutely necessary.

6. Tables/figures/charts/diagrams: All in total should not exceed the number specified for the section for which the submission is made. If more of them are needed, they will be made available only on the website with links in the submission at the relevant places. In the tables, please provide percentages as well as frequencies. Please note that the words used in them are counted as of the submission and so make tables simple and as small as possible with only required text. Tables should only in exceptional cases exceed one page in size, and must be formatted for submission. All acronyms/abbreviations in the tables/figures must be expanded in full in the notes on the table. Tables and Figures must be numbered 1, 2, 3… (Table 1, 2, 3, …; Figure 1, 2, 3, ….) with self-explanatory titles, and referenced in the text. If tables and figures are obtained or reproduced from third party sources, the authors must ensure that, if required, proper permissions have been taken, and all sources are accurately cited.

For submission reporting findings of an empirical study, the editor/reviewer may request more tables or anonymised raw data or codes used for analysis for further scrutiny.

7. Style: The IJME’s readership includes people from different academic and work backgrounds such as medicine, public health, research, health activism, law, philosophy, history and so on. Please write in a clear and direct style. Use the active voice, avoid long sentences, make the minimum use of abbreviations, and spell out acronyms the first time they are used. Please keep the title short, simple and relevant, and use subheads to break up the text in long articles. If necessary, seek the assistance of a writer, giving them appropriate credit in the acknowledgements section of the article. Since IJME is also read by general readers, please avoid using text with diacritical marks except if used frequently or if used in names.

8. Referencing: The journal follows the ICMJE’s Uniform Requirements for references. General rules for this may be found at www.nlm.nih.gov/bsd/uniform_requirements.html, with details in the book Citing Medicine, available from: http://www.ncbi.nlm.nih.gov/books/NBK7256/ . References may be formatted in the IJME style once the article is accepted.

References should be complete, with details of the author/s, title, publication title, publishers, and place and date of publication. For Internet references, a link to the cited work is necessary, with the citation date. A typical format for references is:

Gopichandran V. Trust in healthcare: an evolving concept. Indian J Med Ethics. 2013 Apr–Jun [cited 2017 May 3];10(2):79–82. Available from: https://doi.org/10.20529/IJME.2013.027

References should be numbered consecutively in the order in which they appear in the text, with the same number recurring for repeated citations. These numbers should appear within square brackets in the text, and not in superscript, with the full list of references provided at the end of the article.

During final revision of the submission, authors need to ensure that all endnotes and references are formatted as per the Journal style. Authors need to also ensure that the references and endnotes must be listed at the end of the manuscript, and not below each page in the word document.

Please limit the references to those essential to justify the point being made.

Personal communications as references are discouraged. If the communication is essential to the submission, the author must obtain emailed consent from the person being quoted. This consent should be sent directly to the journal and carry the person’s address, affiliation and telephone details. Such communications should be cited in parentheses in the text, with the name, subject and date of the communication. For unpublished scientific articles, please obtain written permission and confirmation of accuracy from the source.

References must be verified against the original documents before the article is submitted. The author is responsible for the accuracy of the references and for the links being functional.

Papers with incomplete references will be returned to the authors for correction before being sent for review. Authors of accepted manuscripts will be required to rework the references to comply with the IJME format before the manuscripts are processed for publication

9. Line numbering: Add line numbers continuously to the entire document before submitting the manuscript. Steps to add line numbers are:

a) On the Page Layout tab, in the Page Setup group, click Line Numbers

b) Select the option Continuous.

c) You will notice that on the left side of the page, the line numbers have been added.

REVIEW PROCESS

Submissions are reviewed initially by one of the editors and declined if their focus is not relevant to the journal or is not of interest to the journal. All submissions which fall within the purview of the journal are peer reviewed. Submissions are peer reviewed irrespective of whether they were submitted directly by the authors or commissioned by the journal. Submissions for the different sections of the journal are peer reviewed as per the following:

As a policy, IJME supports an unblinded peer review system where the names and details of the authors, reviewers and review reports are disclosed in the public domain. However, currently it is using the “single blinded” review system under which the names and other details of authors are disclosed to reviewers, but the names and other details of reviewers are not disclosed to authors. In order to make the transition to an unblinded “review disclosure” system, IJME encourages and provides reviewers the option to allow IJME to disclose their names and other details alongside the publication of the manuscripts reviewed by them.

ANTI-PLAGIARISM POLICY

Plagiarism is the use of others’ published (print or electronic) and unpublished ideas or words (or other intellectual property), in whole or in part, without proper attribution or permission, and presenting them as new and original work of one’s own rather than derived from an existing source. The act of referencing a passage verbatim from previously published material is also considered as plagiarism. Please rephrase or summarise any statement taken from another source along with citing the appropriate reference. The journal will investigate if plagiarism is detected and will retract a plagiarised article along with informing the head of institution the author is associated to. For more information about plagiarism, please visit the link https://wame.org/recommendations-on-publication-ethics-policies-for-medical-journals#Plagiarism

POLICY ON THE USE OF THE ARTICIFICAL INTELLIGENCE

Please make complete and honest disclosure of the aid taken of any Artificial Intelligence in the preparation of manuscript. The disclosure must be in full detail and strictly as per the recommendations of the World Association of Medical Editors (WAME): https://wame.org/page3.php?id=106

EDITORIAL DECISION, ARTICLE PROCESSING CHARGE (APC), COPYEDITING, COPYRIGHTS

1. Processing a submission: A submission goes through the following steps of processing

1. Acknowledgement of receipt of the submission with a cover letter providing the requisite information.

2. A preliminary assessment of the submission by the editorial office and a Working Editor (WE), and plagiarism check.

3. If the initial assessment is positive, assignment of the submission to reviewer(s)

4. Receipt of peer review reports/comments, evaluation by the WE and communication of the decision to the author(s). The Editor may reject the submission at this stage, or ask for revisions

5. Revision of the submission by authors, based on the reviewers’ comments. Authors are expected to respond to each of the comments either by making the required changes or by explaining their decision not to make the change. The author must resubmit revised manuscript within 90 days of receipt of peer review comments. Thereafter, unless requested by the author otherwise, the submission will be marked as “withdrawn” and archived.

6. Assessment of the revised manuscript by the WE and recommendation to the Editor

7. Assessment of all documents and the final manuscript by the Editor to arrive at a final decision

8. Communication of the decision to the author(s)

9. If the article is accepted, the author is expected to reply accepting the terms of publication

10. Copyediting; the article will be sent for publication only after the author approves of the copyedited manuscript

11. Publication

2. Editorial decision: Revised submissions may be sent back to the original reviewers for their opinion before the final editorial decision is taken. The IJME editors are responsible for monitoring and ensuring the fairness, comprehensiveness, timeliness and civility of the peer-review process. All final decisions on submissions are made by the Editor. The Forum for Medical Ethics Society, the publisher and owner of the journal, has no role in editorial decision-making.

3. Article Processing Charge (APC): The payment of the APC is not mandatory, nor a specific fee is stipulated. If you, your project or institution has funds for publication, we request you to voluntarily make payment of an amount of APC that you can afford — it is called PayWhatYouWant (PWYW). Such voluntary payment of APC will help in sustaining the journal.

4. Copyediting: Articles accepted for publication may be edited for language, clarity and length. The author(s) will be sent the copyedited manuscript by email for pre-publication approval. At that time, they may also be asked to clarify certain points raised by the copyeditor. Authors are requested to aid the demands of production and respond to the corrected manuscript within five days. Changes to the copyedited manuscript must be restricted to responding to queries and correcting errors. All changes should be in track change mode in the text of the returned file with a new filename.

5. Publication and author’s access: We try to publish accepted articles ahead of print in the ‘Online First’ section to reduce delays. However, this is at the Editor’s discretion. Authors in India will receive a complimentary copy of the issue in which their article is published. Authors outside India will receive a PDF copy of the issue. PDF files of all articles will also be available on the website as soon as the article is uploaded, either as Online First or as part of the quarterly issue. All articles published in the IJME are available open access on its website with a request to PayWhatYouWant.

6. Journal’s copyright and Authors’ rights: The authors are required to provide copyright for the published manuscript to the IJME. The published material is open access online, and the print material is accessible to subscribers. The authors, on the other hand, are at liberty to deposit all versions (submitted, revised, published) of their manuscripts in their institutional and other repositories.

7. Creative Commons License: The reproduction of material published by IJME is covered by a Creative Commons license – Attribution, Non-Commercial, Non-Derivatives, 4.0 International ( CC BY-NC-ND 4.0 ). Accordingly, we provide permission for the reproduction of the IJME material without modification for non-commercial purposes, but the IJME allows modifications and commercial use of the material only on payment. For more information, please contact [email protected] .

Page Footer IJME Logo

  • Email pub.ijmar@gmail.com

Indian Journal of Medical and Allied Research

Indian Journal of Medical and Allied Research

  • Email pub.ijmar@gmail.com

Current Issue

indian journal of medical research submission guidelines

Application of Call Score in Predicting Progression Risk in Covid- 19 Patients: A Retrospective Study

Dr Biswas D Kartha, Dr Suresh P

Volume 13, Issue 4, October 2023 pp 1-9.

Gallery Of Nutraceuticals And Dietary Supplements In India

Kiran Kumar* 1 , Adkar Prafulla Prakash 2

Volume 13, Issue 1, July 2023 pp 1-11.

Technique For The Preparation Of Porous Hydrogels And Its Application

Joju Joseph Kattakayam* 1 , Adkar Prafulla Prakash 2

Volume 13, Issue 1, July 2023 pp 12-16.

Quality Management System (QMS) Quality Planning, Quality Control And Quality Improvement

Arun Kumar L N 1*, Sanjeev Kumar Saxena 2

Volume 13, Issue 1, July 2023 pp 17-30.

A Randomised Placebo-Controlled Clinical Trial To Evaluate The Efficacy Of Marigold Extract On Cognitive Performance And Mood In Adults With Stroke And Parkinson’s Disease

C A Anzar* 1 , Joseph M V 1 , C P Prasad 1 , Vadiraj G Bharawaj 1 , Prasanna Anjaneya Reddy Lebaka 1 , Shobith Jagadeesh 2

Volume 12, Issue 4, May 2023 pp 1-7.

Effect Of End Stage Renal Disease And Acute Kidney Injury On ICU Patients With Sepsis

*Ragesh Gurumoorthi, 1 Deepika Anbalagan, 1 Haritha Muthukumaran, 1 Nandagopal Gubendran, 1 Praveen Rasalmohan

Volume 12, Issue 3, April 2023 pp 1-10.

PHARMACEUTICAL PRODUCT REGISTRATION IN SAUDI ARABIA

Mohammed Hussain M 1 , Sangamesh Puranik 2

Volume 12, Issue 2, March 2023 pp 1-7.

Stability Study Of Optimized Formulation

Joju Joseph Kattakayam 1 , Sangamesh Puranik 2

Volume 12, Issue 2, March 2023 pp 8-17.

A STUDY ON CLINICAL DECISION TOOLS: Optimizing Clinical Outcomes with Decision Support Tools

Dr Gulab Bhimrao Tilekar 1 , Dr Varun Patil 2

Volume 12, Issue 1, Feb 2023 pp 1-3.

A Randomized, Multi-Centre, Double Blind, Placebo-Controlled, Three Arm Study To Evaluate The Safety And Efficacy Of iCoffee In Managing Post-Prandial Blood Glucose Levels In Healthy Volunteers

C A Anzar 1 , Joseph M V 2 , Vadiraj G Bharawaj 2 *, Shariq Afsar Thandu 2 , Prasanna Anjaneya Reddy Lebaka 2

Volume 12, Issue 1, Feb 2023 pp 4-19.

For Authors

  • Call For Paper
  • Author Guidelines
  • Editorial Board

Publish Articles Within 48 Hours

Publish your research with IJMAR Journal and engage with global scientific minds.

About IJMAR

Journal Frequency: Monthly

Paper Submission: Throughout the month

Acceptance Notification: Within 24 Hrs

Publish Notification: Within 48 Hrs

indian journal of medical research submission guidelines

Submission guidelines

Manuscript preparation, manuscript submission, manuscript submission checklist, artwork and illustrations guidelines, supplementary information (si), review process, editing services, ethical responsibilities of authors, authorship principles, compliance with ethical standards, competing interests, research involving human participants, their data or biological material, informed consent, open access publishing.

  • Mistakes to avoid during manuscript preparation

Instructions for authors

• The Indian Journal of Pediatrics is a peer-reviewed, double-blinded monthly journal that publishes original articles, review articles, case reports which provide new information, letters in relation to published articles, scientific research letters, picture of the month, announcements (meetings, courses, job advertisements); summary report of conferences, commentaries, grand rounds, clinico-pathological conferences and book reviews.

• Original articles should ordinarily be limited to 2500 words with about 30 references and 4-5 figures/tables.

• Review articles should not exceed 3000 words with not more than 45 references. Review articles are mostly invited articles which are published as part of Special symposium. The titles and prospective authors are selected by the guest editors.

• Clinical Briefs must not exceed 800 words with one figure or table and about 10 references.

• Scientific research letters should be within 350 words, with 5 references and no figure or table.

• Picture of the Month should have a brief case history and a commentary, all fitting on one page along with the pictures.

• Commentary should run to maximum 500 words with 5 latest references, running to maximum 1.5 pages.

• Clinico-pathological conferences should run to maximum 3000 words with maximum of 4 figures/tables and headings like clinical protocol, pathology protocol, final autopsy diagnosis, open forum, discussion with maximum of 20-25 references.

• Grand round should run to maximum 2500 words with 30 references. Format should be introduction, presentation of case and discussion. The discussion should be referenced.

All manuscripts must be accompanied by a signed Copyright Transfer Form which is available at

This can be submitted as a scanned copy. This form states that “The undersigned author(s) certify(ies) that the article is original, is not under consideration by any other journal, and has not been previously published. All copyright ownership of the manuscript entitled (title of article) is hereby transferred to the publishers of the Indian Journal of Pediatrics.”

The authors should state in the manuscript that ethical clearance was obtained for the research project. The journal has the right to ask for a copy of ethical clearance.

Articles will be edited for style and grammar. Technical jargon is to be kept to a minimum. The book entitled “Scientific Style and Format – The CSE Manual for Authors, Editors and Publishers”, 7th edition, published by Council of Science Editors is a good guide. American spellings are used in the Journal.

All statement and opinions expressed in the manuscripts are those of the authors, and not those of the editor(s) or publishers. The editor(s) and publishers disclaim any responsibility for such material.

The editor(s) and publishers also do not guarantee, warrant or endorse any product or service advertised in the Journal, nor do they guarantee any claim made by the manufacturer of such product of service.

Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.

Permissions

Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.

Online Submission

Please follow the hyperlink “Submit manuscript” and upload all of your manuscript files following the instructions given on the screen.

Source Files

Please ensure you provide all relevant editable source files at every submission and revision. Failing to submit a complete set of editable source files will result in your article not being considered for review. For your manuscript text please always submit in common word processing formats such as .docx or LaTeX.

Additional remark on Online Submission

Authors must submit their article online at www.editorialmanager.com/ijpe/ . Electronic submission substantially reduces the editorial processing, reviewing time and overall publication time. The articles appear on the internet within 2-3 weeks of acceptance as Online First articles.

Please follow the hyperlink “Submit online” on the right and upload all of your manuscript files following the instructions given on the screen.

Online submission. www.editorialmanger.com/ijpe/

- Name, Email and address of author responsible for correspondence.

- For Original Article Structured Abstract of 250 words with 4-6 key words.

- For Review articles and Clinical Briefs non structured Abstract of 250 and 150 words respectively with 4-6 key words.

- References should be cited consecutively in the text in parenthesis.

- Covering letter, including statement of originality and signifying approval of final copy by all authors.

- Copyright Transfer Certificate

- References of latest edition of standard texts like Nelson should be quoted.

- Clearance of the research project by the Institutional Ethics Committee, where ever required.

All editorial correspondence should be sent to Editor-in-Chief, Indian Journal of Pediatrics, 125 (2nd Floor), Gautam Nagar, Behind South Café,

New Delhi 110 049, India.

Tel: 26568098 & 41345105

E-mail: [email protected], [email protected]

Please make sure your title page contains the following information.

The title should be concise and informative.

Author information

  • The name(s) of the author(s)
  • The affiliation(s) of the author(s), i.e. institution, (department), city, (state), country
  • A clear indication and an active e-mail address of the corresponding author
  • If available, the 16-digit ORCID of the author(s)

If address information is provided with the affiliation(s) it will also be published.

For authors that are (temporarily) unaffiliated we will only capture their city and country of residence, not their e-mail address unless specifically requested.

Large Language Models (LLMs), such as ChatGPT , do not currently satisfy our authorship criteria . Notably an attribution of authorship carries with it accountability for the work, which cannot be effectively applied to LLMs. Use of an LLM should be properly documented in the Methods section (and if a Methods section is not available, in a suitable alternative part) of the manuscript.

Please provide a structured abstract of 150 to 250 words which should be divided into the following sections:

  • Purpose (stating the main purposes and research question)

For life science journals only (when applicable)

  • Trial registration number and date of registration for prospectively registered trials
  • Trial registration number and date of registration followed by “retrospectively registered”, for retrospectively registered trials

Please provide 4 to 6 keywords which can be used for indexing purposes.

Statements and Declarations

The following statements should be included under the heading "Statements and Declarations" for inclusion in the published paper. Please note that submissions that do not include relevant declarations will be returned as incomplete.

  • Competing Interests: Authors are required to disclose financial or non-financial interests that are directly or indirectly related to the work submitted for publication. Please refer to “Competing Interests and Funding” below for more information on how to complete this section.

Please see the relevant sections in the submission guidelines for further information as well as various examples of wording. Please revise/customize the sample statements according to your own needs.

Additional remark on Abstract/ Keywords

Abstracts should be as follows:

• For original articles a structured abstract of 250 words which should be divided into the following sections: Objectives (stating the main purposes and research question), Methods, Results and Conclusions.

• For Clinical Briefs and Clinico-pathological Conferences: An unstructured abstract running into 150 words should be provided.

• For Review Articles and Grand Rounds: A non-structured abstract running to 250 words should be provided.

• Scientific Letter to the Editor/ Correspondence / Picture of the Month / Commentary: No Abstract is required.

Provide 4 to 6 keywords which can be used for indexing purposes. (For Original Articles, Clinical Brief and Review articles Grand Rounds and Clinico-pathological Conferences only.)

Text Formatting

Manuscripts should be submitted in Word.

  • Use a normal, plain font (e.g., 10-point Times Roman) for text.
  • Use italics for emphasis.
  • Use the automatic page numbering function to number the pages.
  • Do not use field functions.
  • Use tab stops or other commands for indents, not the space bar.
  • Use the table function, not spreadsheets, to make tables.
  • Use the equation editor or MathType for equations.
  • Save your file in docx format (Word 2007 or higher) or doc format (older Word versions).

Manuscripts with mathematical content can also be submitted in LaTeX. We recommend using Springer Nature’s LaTeX template .

Please use no more than three levels of displayed headings.

Abbreviations

Abbreviations should be defined at first mention and used consistently thereafter.

Footnotes can be used to give additional information, which may include the citation of a reference included in the reference list. They should not consist solely of a reference citation, and they should never include the bibliographic details of a reference. They should also not contain any figures or tables.

Footnotes to the text are numbered consecutively; those to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data). Footnotes to the title or the authors of the article are not given reference symbols.

Always use footnotes instead of endnotes.

Acknowledgments

Acknowledgments of people, grants, funds, etc. should be placed in a separate section on the title page. The names of funding organizations should be written in full.

Additional remarks on Text

Text formatting

Original Articles must consider and follow the format: Introduction, Material and Methods, Results, Discussion, and Conclusions. The matter must be written in a manner which is easy to understand, and should be restricted to the topic discussed. Do not use vertical lines or underlining in the text.

Abbreviate measurements (cm, ml) according to the style of CSE Manual for Authors, Editors and Publishers, 7th edition, published by Council of Science Editors. Abbreviations should be used sparingly and must be preceded by the full form initially. Avoid abbreviations in the title and abstract.

Year, month, week, day, hour, minute and second should be abbreviated as y, mo, wk, d, h, min, and s, respectively.

Acknowledgements

Acknowledgments of people, grants, funds, etc. should be placed in a separate section at the end of the article. The names of funding organizations should be written in full.

Contributions, Conflict of Interest and Funding Source

Submissions to the Indian Journal of Pediatrics should also include at the end of the article (i) Each author’s contribution (ii) Conflict of interest (iii) Funding source.

References should be cited in the text consecutively and should be identified by numbers in square brackets. Some examples: 1. Negotiation research spans many disciplines [3]. 2. This result was later contradicted by Becker and Seligman [5]. 3. This effect has been widely studied [1-3, 7].

Reference list

The list of references should only include works that are cited in the text and that have been published or accepted for publication. Personal communications and unpublished works should only be mentioned in the text. Do not use footnotes or endnotes as a substitute for a reference list.The entries in the list should be numbered consecutively.

Journal article

Smith JJ. The world of science. Am J Sci. 1999;36:234–5.

Article by DOI Slifka MK, Whitton JL. Clinical implications of dysregulated cytokine production. J Mol Med. 2000; doi:10.1007/s001090000086

Blenkinsopp A, Paxton P. Symptoms in the pharmacy: a guide to the management of common illness. 3rd ed. Oxford: Blackwell Science; 1998.

Book chapter

Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. In: Bourne GH, Danielli JF, Jeon KW, eds. International review of cytology. London: Academic; 1980. pp. 251–306.

Online document

Doe J. Title of subordinate document. In: The dictionary of substances and their effects. Royal Society of Chemistry. 1999. http://www.rsc.org/dose/title of subordinate document. Accessed 15 Jan 1999.

Always use the standard abbreviation of a journal’s name according to the ISSN List of Title Word Abbreviations, see

www.issn.org/2-22661-LTWA-online.php

For authors using EndNote, Springer provides an output style that supports the formatting of in-text citations and reference list.

EndNote style (zip, 3 kB)

In citing other work, only references consulted in the original should be included. If it is against citation by others this should also be stated.

The Journal follows the Vancouver system of references. References should be numbered and listed consecutively in the order in which they are first cited in the text. Responsibility for the accuracy and completeness of references lies with the author.

The list of references should only include works that are cited in the text and that have been published or accepted for publication. Personal communications and unpublished works should only be mentioned in the text. Do not use footnotes or endnotes as a substitute for a reference list. The entries in the list should be numbered consecutively.

Journal Article

Last names and initials of all authors (unless more than 6 when only 1st three are given followed by et al). The title of the paper; journal title abbreviated according to the style of Index Medicus, year of publication; volume no; first and last page numbers.

Mehta MN, Mehta JN. Serum lipids and ABO blood groups in cord blood of neonates. Indian J Pediatr. 1984;51:30-43.

Give authors’ name followed by the book title, edition no, place of publication, publisher and year.

Smith GDL. Chronic Ear Disease. Edinburgh: Churchill Livingstone; 1980. p. 78-81.

Book Chapter

Provide authors’ names, chapter title, editors names, book title, place of publication, publisher, year and page range.

Malhotra KC. Medicogenetic problems of Indian tribes. In: Verma IC, editor. Medical Genetics in India, Vol. 2. Pondicherry: Auroma Enterprises; 1978. p. 51-5.

Papers accepted but not yet published should be included in the references followed by “In press”. Those in preparation, personal communications and unpublished observations should be referred to as such in the text only.

For more detailed information about the Vancouver system, authors should consult “Uniform requirements for manuscripts submitted to biomedical journals’ (Br Med J. 1982; 284: 1766-70).

Online Document

Doe J. Title of subordinate document. In: The dictionary of substances and their effects. Royal Society of Chemistry. 1999. Available at: http://www.rsc.org/dose/title of subordinate document. Accessed on 15 Jan 1999.

  • All tables are to be numbered using Arabic numerals.
  • Tables should always be cited in text in consecutive numerical order.
  • For each table, please supply a table caption (title) explaining the components of the table.
  • Identify any previously published material by giving the original source in the form of a reference at the end of the table caption.
  • Footnotes to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data) and included beneath the table body.

Please note:

Abbreviations used in the table should be expanded in the footnote to the table.

Electronic Figure Submission

  • Supply all figures electronically.
  • Indicate what graphics program was used to create the artwork.
  • For vector graphics, the preferred format is EPS; for halftones, please use TIFF format. MSOffice files are also acceptable.
  • Vector graphics containing fonts must have the fonts embedded in the files.
  • Name your figure files with "Fig" and the figure number, e.g., Fig1.eps.
  • Definition: Black and white graphic with no shading.
  • Do not use faint lines and/or lettering and check that all lines and lettering within the figures are legible at final size.
  • All lines should be at least 0.1 mm (0.3 pt) wide.
  • Scanned line drawings and line drawings in bitmap format should have a minimum resolution of 1200 dpi.

Halftone Art

indian journal of medical research submission guidelines

  • Definition: Photographs, drawings, or paintings with fine shading, etc.
  • If any magnification is used in the photographs, indicate this by using scale bars within the figures themselves.
  • Halftones should have a minimum resolution of 300 dpi.

Combination Art

indian journal of medical research submission guidelines

  • Definition: a combination of halftone and line art, e.g., halftones containing line drawing, extensive lettering, color diagrams, etc.
  • Combination artwork should have a minimum resolution of 600 dpi.
  • Color art is free of charge for online publication.
  • If black and white will be shown in the print version, make sure that the main information will still be visible. Many colors are not distinguishable from one another when converted to black and white. A simple way to check this is to make a xerographic copy to see if the necessary distinctions between the different colors are still apparent.
  • If the figures will be printed in black and white, do not refer to color in the captions.
  • Color illustrations should be submitted as RGB (8 bits per channel).

Figure Lettering

  • To add lettering, it is best to use Helvetica or Arial (sans serif fonts).
  • Keep lettering consistently sized throughout your final-sized artwork, usually about 2–3 mm (8–12 pt).
  • Variance of type size within an illustration should be minimal, e.g., do not use 8-pt type on an axis and 20-pt type for the axis label.
  • Avoid effects such as shading, outline letters, etc.
  • Do not include titles or captions within your illustrations.

Figure Numbering

  • All figures are to be numbered using Arabic numerals.
  • Figures should always be cited in text in consecutive numerical order.
  • Figure parts should be denoted by lowercase letters (a, b, c, etc.).
  • If an appendix appears in your article and it contains one or more figures, continue the consecutive numbering of the main text. Do not number the appendix figures,"A1, A2, A3, etc." Figures in online appendices [Supplementary Information (SI)] should, however, be numbered separately.

Figure Captions

  • Each figure should have a concise caption describing accurately what the figure depicts. Include the captions in the text file of the manuscript, not in the figure file.
  • Figure captions begin with the term Fig. in bold type, followed by the figure number, also in bold type.
  • No punctuation is to be included after the number, nor is any punctuation to be placed at the end of the caption.
  • Identify all elements found in the figure in the figure caption; and use boxes, circles, etc., as coordinate points in graphs.
  • Identify previously published material by giving the original source in the form of a reference citation at the end of the figure caption.

Figure Placement and Size

  • Figures should be submitted within the body of the text. Only if the file size of the manuscript causes problems in uploading it, the large figures should be submitted separately from the text.
  • When preparing your figures, size figures to fit in the column width.
  • For large-sized journals the figures should be 84 mm (for double-column text areas), or 174 mm (for single-column text areas) wide and not higher than 234 mm.
  • For small-sized journals, the figures should be 119 mm wide and not higher than 195 mm.

If you include figures that have already been published elsewhere, you must obtain permission from the copyright owner(s) for both the print and online format. Please be aware that some publishers do not grant electronic rights for free and that Springer will not be able to refund any costs that may have occurred to receive these permissions. In such cases, material from other sources should be used.

Accessibility

In order to give people of all abilities and disabilities access to the content of your figures, please make sure that

  • All figures have descriptive captions (blind users could then use a text-to-speech software or a text-to-Braille hardware)
  • Patterns are used instead of or in addition to colors for conveying information (colorblind users would then be able to distinguish the visual elements)
  • Any figure lettering has a contrast ratio of at least 4.5:1

Generative AI Images

Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein.

Springer accepts electronic multimedia files (animations, movies, audio, etc.) and other supplementary files to be published online along with an article or a book chapter. This feature can add dimension to the author's article, as certain information cannot be printed or is more convenient in electronic form.

Before submitting research datasets as Supplementary Information, authors should read the journal’s Research data policy. We encourage research data to be archived in data repositories wherever possible.

  • Supply all supplementary material in standard file formats.
  • Please include in each file the following information: article title, journal name, author names; affiliation and e-mail address of the corresponding author.
  • To accommodate user downloads, please keep in mind that larger-sized files may require very long download times and that some users may experience other problems during downloading.
  • High resolution (streamable quality) videos can be submitted up to a maximum of 25GB; low resolution videos should not be larger than 5GB.

Audio, Video, and Animations

  • Aspect ratio: 16:9 or 4:3
  • Maximum file size: 25 GB for high resolution files; 5 GB for low resolution files
  • Minimum video duration: 1 sec
  • Supported file formats: avi, wmv, mp4, mov, m2p, mp2, mpg, mpeg, flv, mxf, mts, m4v, 3gp

Text and Presentations

  • Submit your material in PDF format; .doc or .ppt files are not suitable for long-term viability.
  • A collection of figures may also be combined in a PDF file.

Spreadsheets

  • Spreadsheets should be submitted as .csv or .xlsx files (MS Excel).

Specialized Formats

  • Specialized format such as .pdb (chemical), .wrl (VRML), .nb (Mathematica notebook), and .tex can also be supplied.

Collecting Multiple Files

  • It is possible to collect multiple files in a .zip or .gz file.
  • If supplying any supplementary material, the text must make specific mention of the material as a citation, similar to that of figures and tables.
  • Refer to the supplementary files as “Online Resource”, e.g., "... as shown in the animation (Online Resource 3)", “... additional data are given in Online Resource 4”.
  • Name the files consecutively, e.g. “ESM_3.mpg”, “ESM_4.pdf”.
  • For each supplementary material, please supply a concise caption describing the content of the file.

Processing of supplementary files

  • Supplementary Information (SI) will be published as received from the author without any conversion, editing, or reformatting.

In order to give people of all abilities and disabilities access to the content of your supplementary files, please make sure that

  • The manuscript contains a descriptive caption for each supplementary material
  • Video files do not contain anything that flashes more than three times per second (so that users prone to seizures caused by such effects are not put at risk)

The journal is a peer-reviewed, double-blinded journal. Each article is reviewed by at least two reviewers competent in that sub-specialty. We provide 10 days to the reviewer to accept the invitation to review the manuscript and 30 days to review. The average time taken by reviewers to review the manuscript is 3 weeks.

How can you help improve your manuscript for publication?

Presenting your work in a well-structured manuscript and in well-written English gives it its best chance for editors and reviewers to understand it and evaluate it fairly. Many researchers find that getting some independent support helps them present their results in the best possible light. The experts at Springer Nature Author Services can help you with manuscript preparation—including English language editing, developmental comments, manuscript formatting, figure preparation, translation , and more.

Get started and save 15%

You can also use our free Grammar Check tool for an evaluation of your work.

Please note that using these tools, or any other service, is not a requirement for publication, nor does it imply or guarantee that editors will accept the article, or even select it for peer review.

Chinese (中文)

您怎么做才有助于改进您的稿件以便顺利发表?

如果在结构精巧的稿件中用精心组织的英语展示您的作品,就能最大限度地让编辑和审稿人理解并公正评估您的作品。许多研究人员发现,获得一些独立支持有助于他们以尽可能美好的方式展示他们的成果。Springer Nature Author Services 的专家可帮助您准备稿件,具体包括 润色英语表述、添加有见地的注释、为稿件排版、设计图表、翻译 等。

开始使用即可节省 15% 的费用

您还可以使用我们的 免费语法检查工具 来评估您的作品。

请注意,使用这些工具或任何其他服务不是发表前必须满足的要求,也不暗示或保证相关文章定会被编辑接受(甚至未必会被选送同行评审)。

Japanese (日本語)

発表に備えて、論文を改善するにはどうすればよいでしょうか?

内容が適切に組み立てられ、質の高い英語で書かれた論文を投稿すれば、編集者や査読者が論文を理解し、公正に評価するための最善の機会となります。多くの研究者は、個別のサポートを受けることで、研究結果を可能な限り最高の形で発表できると思っています。Springer Nature Author Servicesのエキスパートが、 英文の編集、建設的な提言、論文の書式、図の調整、翻訳 など、論文の作成をサポートいたします。

今なら15%割引でご利用いただけます

原稿の評価に、無料 の文法チェック ツールもご利用いただけます。

これらのツールや他のサービスをご利用いただくことは、論文を掲載するための要件ではありません。また、編集者が論文を受理したり、査読に選定したりすることを示唆または保証するものではないことにご注意ください。

Korean (한국어)

게재를 위해 원고를 개선하려면 어떻게 해야 할까요?

여러분의 작품을 체계적인 원고로 발표하는 것은 편집자와 심사자가 여러분의 연구를 이해하고 공정하게 평가할 수 있는 최선의 기회를 제공합니다. 많은 연구자들은 어느 정도 독립적인 지원을 받는 것이 가능한 한 최선의 방법으로 자신의 결과를 발표하는 데 도움이 된다고 합니다. Springer Nature Author Services 전문가들은 영어 편집, 발전적인 논평, 원고 서식 지정, 그림 준비, 번역 등과 같은 원고 준비를 도와드릴 수 있습니다.

지금 시작하면 15% 할인됩니다.

또한 당사의 무료 문법 검사 도구를 사용하여 여러분의 연구를 평가할 수 있습니다.

이러한 도구 또는 기타 서비스를 사용하는 것은 게재를 위한 필수 요구사항이 아니며, 편집자가 해당 논문을 수락하거나 피어 리뷰에 해당 논문을 선택한다는 것을 암시하거나 보장하지는 않습니다.

This journal is committed to upholding the integrity of the scientific record. As a member of the Committee on Publication Ethics ( COPE ) the journal will follow the COPE guidelines on how to deal with potential acts of misconduct.

Authors should refrain from misrepresenting research results which could damage the trust in the journal, the professionalism of scientific authorship, and ultimately the entire scientific endeavour. Maintaining integrity of the research and its presentation is helped by following the rules of good scientific practice, which include*:

  • The manuscript should not be submitted to more than one journal for simultaneous consideration.
  • The submitted work should be original and should not have been published elsewhere in any form or language (partially or in full), unless the new work concerns an expansion of previous work. (Please provide transparency on the re-use of material to avoid the concerns about text-recycling (‘self-plagiarism’).
  • A single study should not be split up into several parts to increase the quantity of submissions and submitted to various journals or to one journal over time (i.e. ‘salami-slicing/publishing’).
  • Concurrent or secondary publication is sometimes justifiable, provided certain conditions are met. Examples include: translations or a manuscript that is intended for a different group of readers.
  • Results should be presented clearly, honestly, and without fabrication, falsification or inappropriate data manipulation (including image based manipulation). Authors should adhere to discipline-specific rules for acquiring, selecting and processing data.
  • No data, text, or theories by others are presented as if they were the author’s own (‘plagiarism’). Proper acknowledgements to other works must be given (this includes material that is closely copied (near verbatim), summarized and/or paraphrased), quotation marks (to indicate words taken from another source) are used for verbatim copying of material, and permissions secured for material that is copyrighted.

Important note: the journal may use software to screen for plagiarism.

  • Authors should make sure they have permissions for the use of software, questionnaires/(web) surveys and scales in their studies (if appropriate).
  • Research articles and non-research articles (e.g. Opinion, Review, and Commentary articles) must cite appropriate and relevant literature in support of the claims made. Excessive and inappropriate self-citation or coordinated efforts among several authors to collectively self-cite is strongly discouraged.
  • Authors should avoid untrue statements about an entity (who can be an individual person or a company) or descriptions of their behavior or actions that could potentially be seen as personal attacks or allegations about that person.
  • Research that may be misapplied to pose a threat to public health or national security should be clearly identified in the manuscript (e.g. dual use of research). Examples include creation of harmful consequences of biological agents or toxins, disruption of immunity of vaccines, unusual hazards in the use of chemicals, weaponization of research/technology (amongst others).
  • Authors are strongly advised to ensure the author group, the Corresponding Author, and the order of authors are all correct at submission. Adding and/or deleting authors during the revision stages is generally not permitted, but in some cases may be warranted. Reasons for changes in authorship should be explained in detail. Please note that changes to authorship cannot be made after acceptance of a manuscript.

*All of the above are guidelines and authors need to make sure to respect third parties rights such as copyright and/or moral rights.

Upon request authors should be prepared to send relevant documentation or data in order to verify the validity of the results presented. This could be in the form of raw data, samples, records, etc. Sensitive information in the form of confidential or proprietary data is excluded.

If there is suspicion of misbehavior or alleged fraud the Journal and/or Publisher will carry out an investigation following COPE guidelines. If, after investigation, there are valid concerns, the author(s) concerned will be contacted under their given e-mail address and given an opportunity to address the issue. Depending on the situation, this may result in the Journal’s and/or Publisher’s implementation of the following measures, including, but not limited to:

  • If the manuscript is still under consideration, it may be rejected and returned to the author.

- an erratum/correction may be placed with the article

- an expression of concern may be placed with the article

- or in severe cases retraction of the article may occur.

The reason will be given in the published erratum/correction, expression of concern or retraction note. Please note that retraction means that the article is maintained on the platform , watermarked “retracted” and the explanation for the retraction is provided in a note linked to the watermarked article.

  • The author’s institution may be informed
  • A notice of suspected transgression of ethical standards in the peer review system may be included as part of the author’s and article’s bibliographic record.

Fundamental errors

Authors have an obligation to correct mistakes once they discover a significant error or inaccuracy in their published article. The author(s) is/are requested to contact the journal and explain in what sense the error is impacting the article. A decision on how to correct the literature will depend on the nature of the error. This may be a correction or retraction. The retraction note should provide transparency which parts of the article are impacted by the error.

Suggesting / excluding reviewers

Authors are welcome to suggest suitable reviewers and/or request the exclusion of certain individuals when they submit their manuscripts. When suggesting reviewers, authors should make sure they are totally independent and not connected to the work in any way. It is strongly recommended to suggest a mix of reviewers from different countries and different institutions. When suggesting reviewers, the Corresponding Author must provide an institutional email address for each suggested reviewer, or, if this is not possible to include other means of verifying the identity such as a link to a personal homepage, a link to the publication record or a researcher or author ID in the submission letter. Please note that the Journal may not use the suggestions, but suggestions are appreciated and may help facilitate the peer review process.

These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to.

Authorship clarified

The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before the work is submitted.

The Publisher does not prescribe the kinds of contributions that warrant authorship. It is recommended that authors adhere to the guidelines for authorship that are applicable in their specific research field. In absence of specific guidelines it is recommended to adhere to the following guidelines*:

All authors whose names appear on the submission

1) made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data; or the creation of new software used in the work;

2) drafted the work or revised it critically for important intellectual content;

3) approved the version to be published; and

4) agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

* Based on/adapted from:

ICMJE, Defining the Role of Authors and Contributors,

Transparency in authors’ contributions and responsibilities to promote integrity in scientific publication, McNutt at all, PNAS February 27, 2018

Disclosures and declarations

All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate).

The decision whether such information should be included is not only dependent on the scope of the journal, but also the scope of the article. Work submitted for publication may have implications for public health or general welfare and in those cases it is the responsibility of all authors to include the appropriate disclosures and declarations.

Data transparency

All authors are requested to make sure that all data and materials as well as software application or custom code support their published claims and comply with field standards. Please note that journals may have individual policies on (sharing) research data in concordance with disciplinary norms and expectations.

Role of the Corresponding Author

One author is assigned as Corresponding Author and acts on behalf of all co-authors and ensures that questions related to the accuracy or integrity of any part of the work are appropriately addressed.

The Corresponding Author is responsible for the following requirements:

  • ensuring that all listed authors have approved the manuscript before submission, including the names and order of authors;
  • managing all communication between the Journal and all co-authors, before and after publication;*
  • providing transparency on re-use of material and mention any unpublished material (for example manuscripts in press) included in the manuscript in a cover letter to the Editor;
  • making sure disclosures, declarations and transparency on data statements from all authors are included in the manuscript as appropriate (see above).

* The requirement of managing all communication between the journal and all co-authors during submission and proofing may be delegated to a Contact or Submitting Author. In this case please make sure the Corresponding Author is clearly indicated in the manuscript.

Author contributions

In absence of specific instructions and in research fields where it is possible to describe discrete efforts, the Publisher recommends authors to include contribution statements in the work that specifies the contribution of every author in order to promote transparency. These contributions should be listed at the separate title page.

Examples of such statement(s) are shown below:

• Free text:

All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by [full name], [full name] and [full name]. The first draft of the manuscript was written by [full name] and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Example: CRediT taxonomy:

• Conceptualization: [full name], …; Methodology: [full name], …; Formal analysis and investigation: [full name], …; Writing - original draft preparation: [full name, …]; Writing - review and editing: [full name], …; Funding acquisition: [full name], …; Resources: [full name], …; Supervision: [full name],….

For review articles where discrete statements are less applicable a statement should be included who had the idea for the article, who performed the literature search and data analysis, and who drafted and/or critically revised the work.

For articles that are based primarily on the student’s dissertation or thesis , it is recommended that the student is usually listed as principal author:

A Graduate Student’s Guide to Determining Authorship Credit and Authorship Order, APA Science Student Council 2006

Affiliation

The primary affiliation for each author should be the institution where the majority of their work was done. If an author has subsequently moved, the current address may additionally be stated. Addresses will not be updated or changed after publication of the article.

Changes to authorship

Authors are strongly advised to ensure the correct author group, the Corresponding Author, and the order of authors at submission. Changes of authorship by adding or deleting authors, and/or changes in Corresponding Author, and/or changes in the sequence of authors are not accepted after acceptance of a manuscript.

  • Please note that author names will be published exactly as they appear on the accepted submission!

Please make sure that the names of all authors are present and correctly spelled, and that addresses and affiliations are current.

Adding and/or deleting authors at revision stage are generally not permitted, but in some cases it may be warranted. Reasons for these changes in authorship should be explained. Approval of the change during revision is at the discretion of the Editor-in-Chief. Please note that journals may have individual policies on adding and/or deleting authors during revision stage.

Author identification

Authors are recommended to use their ORCID ID when submitting an article for consideration or acquire an ORCID ID via the submission process.

Deceased or incapacitated authors

For cases in which a co-author dies or is incapacitated during the writing, submission, or peer-review process, and the co-authors feel it is appropriate to include the author, co-authors should obtain approval from a (legal) representative which could be a direct relative.

Authorship issues or disputes

In the case of an authorship dispute during peer review or after acceptance and publication, the Journal will not be in a position to investigate or adjudicate. Authors will be asked to resolve the dispute themselves. If they are unable the Journal reserves the right to withdraw a manuscript from the editorial process or in case of a published paper raise the issue with the authors’ institution(s) and abide by its guidelines.

Confidentiality

Authors should treat all communication with the Journal as confidential which includes correspondence with direct representatives from the Journal such as Editors-in-Chief and/or Handling Editors and reviewers’ reports unless explicit consent has been received to share information.

To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals.

Authors should include the following statements (if applicable) in a separate section entitled “Compliance with Ethical Standards” when submitting a paper:

  • Disclosure of potential conflicts of interest
  • Research involving Human Participants and/or Animals

Please note that standards could vary slightly per journal dependent on their peer review policies (i.e. single or double blind peer review) as well as per journal subject discipline. Before submitting your article check the instructions following this section carefully.

The corresponding author should be prepared to collect documentation of compliance with ethical standards and send if requested during peer review or after publication.

The Editors reserve the right to reject manuscripts that do not comply with the above-mentioned guidelines. The author will be held responsible for false statements or failure to fulfill the above-mentioned guidelines.

Authors are requested to disclose interests that are directly or indirectly related to the work submitted for publication. Interests within the last 3 years of beginning the work (conducting the research and preparing the work for submission) should be reported. Interests outside the 3-year time frame must be disclosed if they could reasonably be perceived as influencing the submitted work. Disclosure of interests provides a complete and transparent process and helps readers form their own judgments of potential bias. This is not meant to imply that a financial relationship with an organization that sponsored the research or compensation received for consultancy work is inappropriate.

Editorial Board Members and Editors are required to declare any competing interests and may be excluded from the peer review process if a competing interest exists. In addition, they should exclude themselves from handling manuscripts in cases where there is a competing interest. This may include – but is not limited to – having previously published with one or more of the authors, and sharing the same institution as one or more of the authors. Where an Editor or Editorial Board Member is on the author list they must declare this in the competing interests section on the submitted manuscript. If they are an author or have any other competing interest regarding a specific manuscript, another Editor or member of the Editorial Board will be assigned to assume responsibility for overseeing peer review. These submissions are subject to the exact same review process as any other manuscript. Editorial Board Members are welcome to submit papers to the journal. These submissions are not given any priority over other manuscripts, and Editorial Board Member status has no bearing on editorial consideration.

Interests that should be considered and disclosed but are not limited to the following:

Funding: Research grants from funding agencies (please give the research funder and the grant number) and/or research support (including salaries, equipment, supplies, reimbursement for attending symposia, and other expenses) by organizations that may gain or lose financially through publication of this manuscript.

Employment: Recent (while engaged in the research project), present or anticipated employment by any organization that may gain or lose financially through publication of this manuscript. This includes multiple affiliations (if applicable).

Financial interests: Stocks or shares in companies (including holdings of spouse and/or children) that may gain or lose financially through publication of this manuscript; consultation fees or other forms of remuneration from organizations that may gain or lose financially; patents or patent applications whose value may be affected by publication of this manuscript.

It is difficult to specify a threshold at which a financial interest becomes significant, any such figure is necessarily arbitrary, so one possible practical guideline is the following: "Any undeclared financial interest that could embarrass the author were it to become publicly known after the work was published."

Non-financial interests: In addition, authors are requested to disclose interests that go beyond financial interests that could impart bias on the work submitted for publication such as professional interests, personal relationships or personal beliefs (amongst others). Examples include, but are not limited to: position on editorial board, advisory board or board of directors or other type of management relationships; writing and/or consulting for educational purposes; expert witness; mentoring relations; and so forth.

Primary research articles require a disclosure statement. Review articles present an expert synthesis of evidence and may be treated as an authoritative work on a subject. Review articles therefore require a disclosure statement.Other article types such as editorials, book reviews, comments (amongst others) may, dependent on their content, require a disclosure statement. If you are unclear whether your article type requires a disclosure statement, please contact the Editor-in-Chief.

Please note that, in addition to the above requirements, funding information (given that funding is a potential competing interest (as mentioned above)) needs to be disclosed upon submission of the manuscript in the peer review system. This information will automatically be added to the Record of CrossMark, however it is not added to the manuscript itself. Under ‘summary of requirements’ (see below) funding information should be included in the ‘ Declarations ’ section.

Summary of requirements

The above should be summarized in a statement and placed in a ‘Declarations’ section before the reference list under a heading of ‘Funding’ and/or ‘Competing interests’. Other declarations include Ethics approval, Consent, Data, Material and/or Code availability and Authors’ contribution statements.

Please see the various examples of wording below and revise/customize the sample statements according to your own needs.

When all authors have the same (or no) conflicts and/or funding it is sufficient to use one blanket statement.

Examples of statements to be used when funding has been received:

  • Partial financial support was received from [...]
  • The research leading to these results received funding from […] under Grant Agreement No[…].
  • This study was funded by […]
  • This work was supported by […] (Grant numbers […] and […]

Examples of statements to be used when there is no funding:

  • The authors did not receive support from any organization for the submitted work.
  • No funding was received to assist with the preparation of this manuscript.
  • No funding was received for conducting this study.
  • No funds, grants, or other support was received.

Examples of statements to be used when there are interests to declare:

Non-financial interests: Author C is an unpaid member of committee Z.

Non-financial interests: Author A is on the board of directors of Y and receives no compensation as member of the board of directors.

Non-financial interests: none.

Non-financial interests: Author D has served on advisory boards for Company M, Company N and Company O.

Examples of statements to be used when authors have nothing to declare:

  • The authors have no relevant financial or non-financial interests to disclose.
  • The authors have no competing interests to declare that are relevant to the content of this article.
  • All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.
  • The authors have no financial or proprietary interests in any material discussed in this article.

Authors are responsible for correctness of the statements provided in the manuscript. See also Authorship Principles. The Editor-in-Chief reserves the right to reject submissions that do not meet the guidelines described in this section.

Ethics approval

When reporting a study that involved human participants, their data or biological material, authors should include a statement that confirms that the study was approved (or granted exemption) by the appropriate institutional and/or national research ethics committee (including the name of the ethics committee) and certify that the study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. If doubt exists whether the research was conducted in accordance with the 1964 Helsinki Declaration or comparable standards, the authors must explain the reasons for their approach, and demonstrate that an independent ethics committee or institutional review board explicitly approved the doubtful aspects of the study. If a study was granted exemption from requiring ethics approval, this should also be detailed in the manuscript (including the reasons for the exemption).

Retrospective ethics approval

If a study has not been granted ethics committee approval prior to commencing, retrospective ethics approval usually cannot be obtained and it may not be possible to consider the manuscript for peer review. The decision on whether to proceed to peer review in such cases is at the Editor's discretion.

Ethics approval for retrospective studies

Although retrospective studies are conducted on already available data or biological material (for which formal consent may not be needed or is difficult to obtain) ethics approval may be required dependent on the law and the national ethical guidelines of a country. Authors should check with their institution to make sure they are complying with the specific requirements of their country.

Ethics approval for case studies

Case reports require ethics approval. Most institutions will have specific policies on this subject. Authors should check with their institution to make sure they are complying with the specific requirements of their institution and seek ethics approval where needed. Authors should be aware to secure informed consent from the individual (or parent or guardian if the participant is a minor or incapable) See also section on Informed Consent .

If human cells are used, authors must declare in the manuscript: what cell lines were used by describing the source of the cell line, including when and from where it was obtained, whether the cell line has recently been authenticated and by what method. If cells were bought from a life science company the following need to be given in the manuscript: name of company (that provided the cells), cell type, number of cell line, and batch of cells.

It is recommended that authors check the NCBI database for misidentification and contamination of human cell lines. This step will alert authors to possible problems with the cell line and may save considerable time and effort.

Further information is available from the International Cell Line Authentication Committee (ICLAC).

Authors should include a statement that confirms that an institutional or independent ethics committee (including the name of the ethics committee) approved the study and that informed consent was obtained from the donor or next of kin.

Research Resource Identifiers (RRID)

Research Resource Identifiers (RRID) are persistent unique identifiers (effectively similar to a DOI) for research resources. This journal encourages authors to adopt RRIDs when reporting key biological resources (antibodies, cell lines, model organisms and tools) in their manuscripts.

Organism: Filip1 tm1a(KOMP)Wtsi RRID:MMRRC_055641-UCD

Cell Line: RST307 cell line RRID:CVCL_C321

Antibody: Luciferase antibody DSHB Cat# LUC-3, RRID:AB_2722109

Plasmid: mRuby3 plasmid RRID:Addgene_104005

Software: ImageJ Version 1.2.4 RRID:SCR_003070

RRIDs are provided by the Resource Identification Portal . Many commonly used research resources already have designated RRIDs. The portal also provides authors links so that they can quickly register a new resource and obtain an RRID.

Clinical Trial Registration

The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to assess, improve, maintain, promote or modify health, functioning or health conditions” and a health-related outcome is generally defined as a change in the health of a person or population as a result of an intervention.

To ensure the integrity of the reporting of patient-centered trials, authors must register prospective clinical trials (phase II to IV trials) in suitable publicly available repositories. For example www.clinicaltrials.gov or any of the primary registries that participate in the WHO International Clinical Trials Registry Platform .

The trial registration number (TRN) and date of registration should be included as the last line of the manuscript abstract.

For clinical trials that have not been registered prospectively, authors are encouraged to register retrospectively to ensure the complete publication of all results. The trial registration number (TRN), date of registration and the words 'retrospectively registered’ should be included as the last line of the manuscript abstract.

Standards of reporting

Springer Nature advocates complete and transparent reporting of biomedical and biological research and research with biological applications. Authors are recommended to adhere to the minimum reporting guidelines hosted by the EQUATOR Network when preparing their manuscript.

Exact requirements may vary depending on the journal; please refer to the journal’s Instructions for Authors.

Checklists are available for a number of study designs, including:

Randomised trials (CONSORT) and Study protocols (SPIRIT)

Observational studies (STROBE)

Systematic reviews and meta-analyses (PRISMA) and protocols (Prisma-P)

Diagnostic/prognostic studies (STARD) and (TRIPOD)

Case reports (CARE)

Clinical practice guidelines (AGREE) and (RIGHT)

Qualitative research (SRQR) and (COREQ)

Animal pre-clinical studies (ARRIVE)

Quality improvement studies (SQUIRE)

Economic evaluations (CHEERS)

The above should be summarized in a statement and placed in a ‘Declarations’ section before the reference list under a heading of ‘Ethics approval’.

Examples of statements to be used when ethics approval has been obtained:

• All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Bioethics Committee of the Medical University of A (No. ...).

• This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University B (Date.../No. ...).

• Approval was obtained from the ethics committee of University C. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.

• The questionnaire and methodology for this study was approved by the Human Research Ethics committee of the University of D (Ethics approval number: ...).

Examples of statements to be used for a retrospective study:

• Ethical approval was waived by the local Ethics Committee of University A in view of the retrospective nature of the study and all the procedures being performed were part of the routine care.

• This research study was conducted retrospectively from data obtained for clinical purposes. We consulted extensively with the IRB of XYZ who determined that our study did not need ethical approval. An IRB official waiver of ethical approval was granted from the IRB of XYZ.

• This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Human Investigation Committee (IRB) of University B approved this study.

Examples of statements to be used when no ethical approval is required/exemption granted:

• This is an observational study. The XYZ Research Ethics Committee has confirmed that no ethical approval is required.

• The data reproduced from Article X utilized human tissue that was procured via our Biobank AB, which provides de-identified samples. This study was reviewed and deemed exempt by our XYZ Institutional Review Board. The BioBank protocols are in accordance with the ethical standards of our institution and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

All individuals have individual rights that are not to be infringed. Individual participants in studies have, for example, the right to decide what happens to the (identifiable) personal data gathered, to what they have said during a study or an interview, as well as to any photograph that was taken. This is especially true concerning images of vulnerable people (e.g. minors, patients, refugees, etc) or the use of images in sensitive contexts. In many instances authors will need to secure written consent before including images.

Identifying details (names, dates of birth, identity numbers, biometrical characteristics (such as facial features, fingerprint, writing style, voice pattern, DNA or other distinguishing characteristic) and other information) of the participants that were studied should not be published in written descriptions, photographs, and genetic profiles unless the information is essential for scholarly purposes and the participant (or parent/guardian if the participant is a minor or incapable or legal representative) gave written informed consent for publication. Complete anonymity is difficult to achieve in some cases. Detailed descriptions of individual participants, whether of their whole bodies or of body sections, may lead to disclosure of their identity. Under certain circumstances consent is not required as long as information is anonymized and the submission does not include images that may identify the person.

Informed consent for publication should be obtained if there is any doubt. For example, masking the eye region in photographs of participants is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic profiles, authors should provide assurance that alterations do not distort meaning.

Exceptions where it is not necessary to obtain consent:

• Images such as x rays, laparoscopic images, ultrasound images, brain scans, pathology slides unless there is a concern about identifying information in which case, authors should ensure that consent is obtained.

• Reuse of images: If images are being reused from prior publications, the Publisher will assume that the prior publication obtained the relevant information regarding consent. Authors should provide the appropriate attribution for republished images.

Consent and already available data and/or biologic material

Regardless of whether material is collected from living or dead patients, they (family or guardian if the deceased has not made a pre-mortem decision) must have given prior written consent. The aspect of confidentiality as well as any wishes from the deceased should be respected.

Data protection, confidentiality and privacy

When biological material is donated for or data is generated as part of a research project authors should ensure, as part of the informed consent procedure, that the participants are made aware what kind of (personal) data will be processed, how it will be used and for what purpose. In case of data acquired via a biobank/biorepository, it is possible they apply a broad consent which allows research participants to consent to a broad range of uses of their data and samples which is regarded by research ethics committees as specific enough to be considered “informed”. However, authors should always check the specific biobank/biorepository policies or any other type of data provider policies (in case of non-bio research) to be sure that this is the case.

Consent to Participate

For all research involving human subjects, freely-given, informed consent to participate in the study must be obtained from participants (or their parent or legal guardian in the case of children under 16) and a statement to this effect should appear in the manuscript. In the case of articles describing human transplantation studies, authors must include a statement declaring that no organs/tissues were obtained from prisoners and must also name the institution(s)/clinic(s)/department(s) via which organs/tissues were obtained. For manuscripts reporting studies involving vulnerable groups where there is the potential for coercion or where consent may not have been fully informed, extra care will be taken by the editor and may be referred to the Springer Nature Research Integrity Group.

Consent to Publish

Individuals may consent to participate in a study, but object to having their data published in a journal article. Authors should make sure to also seek consent from individuals to publish their data prior to submitting their paper to a journal. This is in particular applicable to case studies. A consent to publish form can be found

here. (Download docx, 36 kB)

The above should be summarized in a statement and placed in a ‘Declarations’ section before the reference list under a heading of ‘Consent to participate’ and/or ‘Consent to publish’. Other declarations include Funding, Competing interests, Ethics approval, Consent, Data and/or Code availability and Authors’ contribution statements.

Sample statements for "Consent to participate" :

Informed consent was obtained from all individual participants included in the study.

Informed consent was obtained from legal guardians.

Written informed consent was obtained from the parents.

Verbal informed consent was obtained prior to the interview.

Sample statements for “Consent to publish” :

The authors affirm that human research participants provided informed consent for publication of the images in Figure(s) 1a, 1b and 1c.

The participant has consented to the submission of the case report to the journal.

Patients signed informed consent regarding publishing their data and photographs.

Sample statements if identifying information about participants is available in the article:

Additional informed consent was obtained from all individual participants for whom identifying information is included in this article.

Images will be removed from publication if authors have not obtained informed consent or the paper may be removed and replaced with a notice explaining the reason for removal.

To find out more about publishing your work Open Access in Indian Journal of Pediatrics , including information on fees, funding and licenses, visit our Open access publishing page .

  • Find a journal
  • Publish with us
  • Track your research

IMAGES

  1. (PDF) TheIndianJournalof MedicalResearch Full text online at www.ijmr.org.in Submit online

    indian journal of medical research submission guidelines

  2. Archives

    indian journal of medical research submission guidelines

  3. The National Medical Journal of India

    indian journal of medical research submission guidelines

  4. (PDF) INDIAN JOURNAL OF APPLIED RESEARCH X 21

    indian journal of medical research submission guidelines

  5. A systematic review of standard treatment guidelines in Indi... : Indian Journal of Medical Research

    indian journal of medical research submission guidelines

  6. (PDF) Indian Journal of Medical Research enters its centenary Year

    indian journal of medical research submission guidelines

VIDEO

  1. How to select the journal for article submission in advanced ways || Private Batch ||

  2. Junior NTR vs Balakrishna వివాదంపై Clarity..!

  3. Comprehensive Cardiopulmonary Life Support (CCLS), Indian Resuscitation Council Federation

  4. National Medical Journal of India : The process and the product

  5. Indian Journal of Physiology and Pharmacology

  6. NCISM New Notification, Part-1 Overview

COMMENTS

  1. Indian Journal of Medical Research

    Open Viewpoint Gaps in translating basic science research from bench to bedside Kshirsagar, N.; Pahuja, M.; Chatterjee, N. S.; More Indian Journal of Medical Research. 158 (3):228-232, September 2023. Favorite

  2. Indian Journal of Medical Research

    Journal Name: Indian Journal of Medical Research Print ISSN: 0971-5916 E-ISSN: 0975-9174 Frequency: Monthly Category: General Medicine Readership: Biomedical researchers Web URL: https://www.ijmr.org.in Subscriptions Rate individual (US$)-Print: 450 Subscriptions Rate institutional (US$)-Print: 450 Subscriptions Rate individual (US$)-Online

  3. Indian Journal of Medical Research

    Publishing with this journal. There are no publication fees ( article processing charges or APCs) to publish with this journal. Look up the journal's: Aims & scope. Instructions for authors. Editorial Board. Double anonymous peer review. Expect on average 32 weeks from submission to publication.

  4. Submission Guidelines: Indian Journal of Clinical Medicine: Sage Journals

    1. What do we publish? 1.1 Aims & Scope 1.2 Article types 1.3 Writing your paper 2. Editorial policies 2.1 Peer review policy 2.2 Authorship 2.3 Acknowledgements 2.4 Funding 2.5 Declaration of conflicting interests 2.6 Research ethics and patient consent 2.7 Clinical trials 2.8 Reporting guidelines 2.9 Research data 3. Publishing policies

  5. Regulatory requirements for clinical trials in India: What academicians

    The revised ICMR guidelines released in 2006 is called the 'Ethical Guidelines for Biomedical Research on Human Participants' and remains valid as of today, and a revised version is expected in 2017. This guideline covers two broad aspects of clinical research - the general principles that need to be followed and guidance regarding special ...

  6. Submissions

    Manuscript submission file size does not exceed 20mb. Manuscripts sent to authors for revision should be returned by Online Submission System within 3 months in a submission of date. The e-mails and address of all authors & co-authors must be written in the sample covering letter. Please submit text, tables and figures in the same files.

  7. Indian Journal of Medical Research

    The Indian Journal of Medical Research is a peer-reviewed open-access medical journal. [1] [2] It is published by Medknow Publications on behalf of the Indian Council of Medical Research. [1] Since 1977, it has been published monthly with six issues per volume. [3] The journal publishes original "technical and clinical studies related to health ...

  8. Submissions

    The following guidelines have been developed drawing on the International Committee of Medical Journal Editors (ICMJE) recommendations and they must be adhered ro when submitting an article: Permission: Authors must obtain permission for a secondary publication from the editors of both the journal in which the original work was published and IJCP.

  9. Submission Guidelines: Indian Journal of Psychological Medicine: Sage

    1. Open Access 2. What do we publish? 2.1 Aims & scope 2.2 Article types 2.3 Writing your paper 3. Editorial policies 3.1 Peer review policy 3.2 Authorship 3.3 Acknowledgements 3.4 Funding 3.5 Declaration of conflicting interests 3.6 Research ethics and patient consent 3.7 Clinical trials 3.8 Reporting guidelines 3.9 Research Data 4.

  10. The revised guidelines of the Medical Council of India for academic

    Many countries have made it mandatory for their medical faculty to do research; some other countries incentivise the conduct and publication of research. Reports have also lamented that the physician-scientist might become an endangered species.[ 1 , 2 ] Thus, linking publications with promotions might benefit both the individual and the society.

  11. Author Guidelines

    Author Guidelines - Indian Journal of Medical and Allied Research Author Guidelines Author Guidelines Manuscript Preparation The manuscript can be prepared using the IJMAR template ( Download Manuscript Template ), or a single-column or double-column word file is accepted for the review process. PAPER FORMAT Manuscript Submission

  12. SUBMISSION GUIDELINES

    1. Statement (s) about the submission: (a) Originality: The submission is an original writing of author (s) and has not been published in, or submitted to other journal (s) for consideration. (b) Pre-print Publication: Pre-print published manuscripts are eligible for submission to IJME.

  13. Submission guidelines

    Instructions for authors Types of Papers Manuscript Submission Title Page Text References Tables Artwork and Illustrations Guidelines Supplementary Information (SI) Ethical Responsibilities of Authors Authorship principles Compliance with Ethical Standards Competing Interests Research involving human participants, their data or biological material

  14. Submission guidelines

    Submission guidelines Contents Instructions for authors Categories of Manuscripts Manuscript Submission The following should be provided during the submission process Title Page Text Scientific style References Tables Artwork and Illustrations Guidelines Supplementary Information (SI) After acceptance Ethical Responsibilities of Authors

  15. Volume 155

    Open Table of Contents Outline | Back to Top Policy Document Institutional end-of-life care policy for inpatients at a tertiary care centre in India: A way forward to provide a system for a dignified death Bhatnagar, ASushma; Biswas, Swagata; Kumar, Abhishek; More Indian Journal of Medical Research. 155 (2):232-242, February 2022.

  16. Submission guidelines

    All authors whose names appear on the submission. 1) made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data; or the creation of new software used in the work; 2) drafted the work or revised it critically for important intellectual content;

  17. Indian Journal of Community Medicine

    Indian Journal of Community Medicine, the official organ of the Indian Association of Preventive and Social Medicine (IAPSM), publishes original research articles focusing on community health, primary health care, epidemiology, biostatistics, public health administration, health care delivery systems, health economics, health promotion, medical sociology/anthropology, social medicine ...

  18. Current Issue

    A Randomized, Multi-Centre, Double Blind, Placebo-Controlled, Three Arm Study To Evaluate The Safety And Efficacy Of iCoffee In Managing Post-Prandial Blood Glucose Levels In Healthy Volunteers. C A Anzar1, Joseph M V2, Vadiraj G Bharawaj2*, Shariq Afsar Thandu2, Prasanna Anjaneya Reddy Lebaka2. Volume 12, Issue 1, Feb 2023 pp 4-19.

  19. Indian Journal of Cancer

    MCQs on "Incidence and clinical profile of brain metastasis treated with whole brain radiotherapy in a tertiary hospital in eastern India: A retrospective audit". Indian Journal of Cancer. 60 (3):403-404, Jul-Sep 2023.

  20. Submission guidelines

    The editors of the Indian Journal of Gastroenterology aspire to support innovative, novel, interesting, ethical and inclusive medical research in the broad speciality of gastroenterology, hepatology, diagnostic and therapeutic endoscopy, organ transplantation and related basic sciences, translational research and emerging therapeutics in the field.

  21. Submission guidelines

    Manuscript Preparation • The Indian Journal of Pediatrics is a peer-reviewed, double-blinded monthly journal that publishes original articles, review articles, case reports which provide new information, letters in relation to published articles, scientific research letters, picture of the month, announcements (meetings, courses, job advertisements); summary report of conferences ...